2638 Teneligliptin 20mg, Metformin Hydrochloride 500mg (Sustained Release) and Pioglitazone 15mg Tablets IP

2638 Teneligliptin 20mg, Metformin Hydrochloride 500mg (Sustained Release) and Pioglitazone 15mg Tablets IP offer a modern, three-pronged approach to diabetes management. Teneligliptin assists in increasing insulin production, Metformin ensures sustained glycemic control, and Pioglitazone improves insulin sensitivity. This synergistic combination helps achieve better blood sugar regulation and improved patient outcomes.